Parametric Portfolio Associates’s Axonics, Inc. Common Stock AXNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$2.75M Buy
43,844
+21,425
+96% +$1.15M ﹤0.01% 2246
2021
Q4
$1.25M Sell
22,419
-18,554
-45% -$1.13M ﹤0.01% 2687
2021
Q3
$2.67M Buy
40,973
+20,723
+102% +$1.41M ﹤0.01% 2256
2021
Q2
$1.28M Buy
20,250
+1,770
+10% +$104K ﹤0.01% 2659
2021
Q1
$1.11M Buy
18,480
+1,690
+10% +$91.9K ﹤0.01% 3117
2020
Q4
$838K Sell
16,790
-23,836
-59% -$1.12M ﹤0.01% 3138
2020
Q3
$2.07M Buy
40,626
+23,825
+142% +$995K ﹤0.01% 2489
2020
Q2
$590K Buy
16,801
+3,978
+31% +$137K ﹤0.01% 3185
2020
Q1
$326K Buy
12,823
+1,148
+10% +$34.1K ﹤0.01% 3374
2019
Q4
$324K Sell
11,675
-23,954
-67% -$572K ﹤0.01% 3539
2019
Q3
$959K Buy
35,629
+2,637
+8% +$91.9K ﹤0.01% 3045
2019
Q2
$1.35M Buy
+32,992
New +$928K ﹤0.01% 2894

Other funds holding AXNX

Parametric Portfolio Associates's AXNX Position: Q1 2022 in Review

Parametric Portfolio Associates increased its Axonics, Inc. Common Stock (AXNX) stake by 96% in Q1 2022, buying an estimated $1.15M and bringing the position to 43,844 shares worth $2.75M. The position accounts for ﹤0.01% of the portfolio, ranked #2246.

Parametric Portfolio Associates first reported a position in AXNX in Q2 2019 and has held it in 12 quarters since. 187 funds tracked by Wall St. Rank hold AXNX as of Q1 2022.

  • Parametric Portfolio Associates held 43,844 shares of Axonics, Inc. Common Stock worth $2.75M as of Q1 2022.
  • Parametric Portfolio Associates bought 21,425 Axonics, Inc. Common Stock shares in Q1 2022, an estimated $1.15M.
  • Axonics, Inc. Common Stock made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #2246 holding.
  • Parametric Portfolio Associates first reported a position in Axonics, Inc. Common Stock in Q2 2019 and has held it in 12 quarters since.
  • 187 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.